<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="2" ids="35475">Nonsteroidal anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAIDs</z:chebi>) and aspirin, which are available as "over-the counter" medications in most countries, are widely used by both pregnant and lactating women </plain></SENT>
<SENT sid="1" pm="."><plain>They are popular non-<z:chebi fb="0" ids="35482">opioid analgesics</z:chebi> for the treatment of pain after vaginal and operative delivery </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, <z:chebi fb="1" ids="35475">NSAIDs</z:chebi> are used for tocolysis in <z:e sem="disease" ids="C0022876" disease_type="Disease or Syndrome" abbrv="">premature labor</z:e>, and low-dose aspirin has a role in the prevention of <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> and <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriage</z:e> in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="1" ids="35475">NSAIDs</z:chebi> and aspirin may affect fertility and increase the risk of early pregnancy loss </plain></SENT>
<SENT sid="4" pm="."><plain>In the second trimester their use is considered reasonably safe, but has been associated with fetal <z:mp ids='MP_0002286'>cryptorchism</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In the third trimester, <z:chebi fb="1" ids="35475">NSAIDs</z:chebi> and aspirin are usually avoided because of significant fetal risks such as renal injury, <z:hpo ids='HP_0001562'>oligohydramnios</z:hpo>, constriction of the <z:hpo ids='HP_0001643'>ductus arteriosus</z:hpo> (with potential for persistent <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> in the newborn), necrotizing <z:hpo ids='HP_0004387'>enterocolitis</z:hpo>, and <z:hpo ids='HP_0002170'>intracranial hemorrhage</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Maternal administration or ingestion of most <z:chebi fb="1" ids="35475">NSAIDs</z:chebi> results in low infant exposure via breastmilk, such that both cyclooxygenase-1 and <z:chebi fb="0" ids="50629">cyclooxygenase-2 inhibitors</z:chebi> are generally considered safe, and preferable to aspirin, when breastfeeding </plain></SENT>
</text></document>